Skip to main content

Table 1 Predictors of high-risk syncope on univariate analysis in the derivation cohort (n = 231)

From: Comparison of existing syncope rules and newly proposed anatolian syncope rule to predict short-term serious outcomes after syncope in the Turkish population

Variable

Syncope without adverse events (n = 192)

N (%)

Syncope with adverse events (n = 39)

N (%)

P

Age > 58

68 (35.4)

32 (82.1)

< 0.001

Presence of tachycardia

23 (11.9)

9 (23.0)

> 0.05

Presence of tachypnea

5 (2.6)

9 (23.1)

< 0.001

Ortostatism

6 (3.1)

8 (20.5)

< 0.001

Co-morbidity

91 (47.4)

33 (84.6)

< 0.001

Polypharmacy

77 (40.1)

31 (78.5)

< 0.001

Abnormal physical examination finding

17 (8.9)

13 (33.3)

< 0.001

History of coronary artery disease

19 (9.9)

11 (28.2)

< 0.005

Presence of a prodrome

37 (19.3)

19 (48.7)

< 0.001

Abnormal ECG

31 (16.1)

28 (71.8)

< 0.001

History of congestive heart failure

9 (4.7)

13 (33.3)

< 0.001

Haematocrit < 30%

6 (3.1)

6 (15.4)

< 0.01

Presence of dyspnea

3 (1.6)

7 (17.9)

< 0.001

Presence of palpitations

15 (7.8)

8 (20.5)

< 0.05

Syncope on exertion

13 (6.8)

10 (25.6)

< 0.005

Syncope when supine

5 (2.6)

7 (17.9)

< 0.001

Any positive finding on auscultation

4 (2.1)

8 (20.5)

< 0.001

Abnormal ECG rhythm

8 (4.2)

8 (20.5)

< 0.005

Wide QRS

2 (1.0)

5 (12.8)

< 0.005

Abnormal ST (depression/elevation)

3 (1.6)

6 (15.4)

< 0.001

Abnormal cardiac axis on ECG

10 (5.2)

7 (17.9)

< 0.05

Presence of atrioventricular block

4 (2.1)

7 (17.9)

< 0.001

Known precipitating cause for syncope

96 (50)

34 (87.2)

< 0.001

  1. ECG: electrocardiogram